Cargando…

Regulation of the collagen cross-linking enzymes LOXL2 and PLOD2 by tumor-suppressive microRNA-26a/b in renal cell carcinoma

Our recent studies of microRNA (miRNA) expression signatures in human cancers revealed that microRNA-26a (miRNA-26a) and microRNA-26b (miRNA-26b) were significantly reduced in cancer tissues. To date, few reports have provided functional analyses of miR-26a or miR-26b in renal cell carcinoma (RCC)....

Descripción completa

Detalles Bibliográficos
Autores principales:	KUROZUMI, AKIRA, KATO, MAYUKO, GOTO, YUSUKE, MATSUSHITA, RYOSUKE, NISHIKAWA, RIKA, OKATO, ATSUSHI, FUKUMOTO, ICHIRO, ICHIKAWA, TOMOHIKO, SEKI, NAOHIKO
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2016
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4809659/ https://www.ncbi.nlm.nih.gov/pubmed/26983694 http://dx.doi.org/10.3892/ijo.2016.3440

Ejemplares similares

Regulation of E3 ubiquitin ligase-1 (WWP1) by microRNA-452 inhibits cancer cell migration and invasion in prostate cancer
por: Goto, Yusuke, et al.
Publicado: (2016)

Tumor‐suppressive microRNA‐223 inhibits cancer cell migration and invasion by targeting ITGA3/ITGB1 signaling in prostate cancer
por: Kurozumi, Akira, et al.
Publicado: (2015)

Direct regulation of LAMP1 by tumor-suppressive microRNA-320a in prostate cancer
por: OKATO, ATSUSHI, et al.
Publicado: (2016)

Tumor-suppressive microRNA-29 family inhibits cancer cell migration and invasion directly targeting LOXL2 in lung squamous cell carcinoma
por: MIZUNO, KEIKO, et al.
Publicado: (2015)

MicroRNA expression signature of castration-resistant prostate cancer: the microRNA-221/222 cluster functions as a tumour suppressor and disease progression marker
por: Goto, Yusuke, et al.
Publicado: (2015)

Impact of novel miR-145-3p regulatory networks on survival in patients with castration-resistant prostate cancer
por: Goto, Yusuke, et al.
Publicado: (2017)

Aberrantly expressed PLOD1 promotes cancer aggressiveness in bladder cancer: a potential prognostic marker and therapeutic target
por: Yamada, Yasutaka, et al.
Publicado: (2019)

The microRNA signature of patients with sunitinib failure: regulation of UHRF1 pathways by microRNA-101 in renal cell carcinoma
por: Goto, Yusuke, et al.
Publicado: (2016)

Dual Strands of Pre-miR-149 Inhibit Cancer Cell Migration and Invasion through Targeting FOXM1 in Renal Cell Carcinoma
por: Okato, Atsushi, et al.
Publicado: (2017)

Regulation of spindle and kinetochore‐associated protein 1 by antitumor miR‐10a‐5p in renal cell carcinoma
por: Arai, Takayuki, et al.
Publicado: (2017)

Regulation of NCAPG by miR‐99a‐3p (passenger strand) inhibits cancer cell aggressiveness and is involved in CRPC
por: Arai, Takayuki, et al.
Publicado: (2018)

Tumour-suppressive miRNA-26a-5p and miR-26b-5p inhibit cell aggressiveness by regulating PLOD2 in bladder cancer
por: Miyamoto, K, et al.
Publicado: (2016)

Roles of PLODs in Collagen Synthesis and Cancer Progression
por: Qi, Yifei, et al.
Publicado: (2018)

LOXL4, but not LOXL2, is the critical determinant of pathological collagen cross-linking and fibrosis in the lung
por: Ma, Hsiao-Yen, et al.
Publicado: (2023)

PB1798: EVALUATION OF EXPRESSION OF PLODS FAMILY GENES (PLOD1, PLOD2, PLOD3) IN PATIENTS WITH ACUTE MYELOID LEUKEMIA
por: Zaker, F., et al.
Publicado: (2022)

The microRNA-23b/27b/24-1 cluster is a disease progression marker and tumor suppressor in prostate cancer
por: Goto, Yusuke, et al.
Publicado: (2014)

Impact of novel oncogenic pathways regulated by antitumor miR‐451a in renal cell carcinoma
por: Yamada, Yasutaka, et al.
Publicado: (2018)

Regulation of antitumor miR‐144‐5p targets oncogenes: Direct regulation of syndecan‐3 and its clinical significance
por: Yamada, Yasutaka, et al.
Publicado: (2018)

Anti-tumor roles of both strands of the miR-455 duplex: their targets SKA1 and SKA3 are involved in the pathogenesis of renal cell carcinoma
por: Yamada, Yasutaka, et al.
Publicado: (2018)

Regulation of Oncogenic Targets by the Tumor-Suppressive miR-139 Duplex (miR-139-5p and miR-139-3p) in Renal Cell Carcinoma
por: Okada, Reona, et al.
Publicado: (2020)

Regulation of ITGA3 by the anti‐tumor miR‐199 family inhibits cancer cell migration and invasion in head and neck cancer
por: Koshizuka, Keiichi, et al.
Publicado: (2017)

Tumor-suppressive microRNA-218 inhibits cancer cell migration and invasion via targeting of LASP1 in prostate cancer
por: Nishikawa, Rika, et al.
Publicado: (2014)

Dual regulation of receptor tyrosine kinase genes EGFR and c-Met by the tumor-suppressive microRNA-23b/27b cluster in bladder cancer
por: CHIYOMARU, TAKESHI, et al.
Publicado: (2014)

Identification of Regulatory Molecular “Hot Spots” for LH/PLOD Collagen Glycosyltransferase Activity
por: Mattoteia, Daiana, et al.
Publicado: (2023)

LOXL2 Inhibition Paves the Way for Macrophage-Mediated Collagen Degradation in Liver Fibrosis
por: Klepfish, Mordehay, et al.
Publicado: (2020)

The Collagen-Modifying Enzyme PLOD2 Is Induced and Required during L1-Mediated Colon Cancer Progression
por: Cheriyamundath, Sanith, et al.
Publicado: (2021)

Deep sequencing-based microRNA expression signatures in head and neck squamous cell carcinoma: dual strands of pre-miR-150 as antitumor miRNAs
por: Koshizuka, Keiichi, et al.
Publicado: (2017)

Loxl2 and Loxl3 Paralogues Play Redundant Roles during Mouse Development
por: Santamaría, Patricia G., et al.
Publicado: (2022)

Abnormal Bone Collagen Cross‐Linking in Osteogenesis Imperfecta/Bruck Syndrome Caused by Compound Heterozygous PLOD2 Mutations
por: Gistelinck, Charlotte, et al.
Publicado: (2021)

The effect of LOXL2 in hepatocellular carcinoma
por: Wu, Linghong, et al.
Publicado: (2016)

COLGALT2 is overexpressed in ovarian cancer and interacts with PLOD3
por: Guo, Ting, et al.
Publicado: (2021)

A Fe(2+)-dependent self-inhibited state influences the druggability of human collagen lysyl hydroxylase (LH/PLOD) enzymes
por: Scietti, Luigi, et al.
Publicado: (2022)

LOXL2 as a protective in osteoarthritis cartilage
por: Bais, Manish V., et al.
Publicado: (2017)

Linking LOXL2 to Cardiac Interstitial Fibrosis
por: Erasmus, Melisse, et al.
Publicado: (2020)

LOXL2 Inhibitors and Breast Cancer Progression
por: Ferreira, Sandra, et al.
Publicado: (2021)

Pan-Cancer Analyses Reveal Oncogenic and Immunological Role of PLOD2
por: Xu, Qiqi, et al.
Publicado: (2022)

Dysregulation of PLOD2 Promotes Tumor Metastasis and Invasion in Hepatocellular Carcinoma
por: Li, Keren, et al.
Publicado: (2023)

LOXL2—A New Target in Antifibrogenic Therapy?
por: Puente, Angela, et al.
Publicado: (2019)

Wnt signaling and Loxl2 promote aggressive osteosarcoma
por: Matsuoka, Kazuhiko, et al.
Publicado: (2020)

LAMA2 and LOXL4 are candidate FSGS genes
por: Vijayan, Poornima, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_lp4utna5p81r6a6rnseifep8sm